Investor List:

Top Digital Health Series B Investors in Canada (19)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Digital Health investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Shalva Gozland, Investor at Insight Partners
Shalva Gozland
Sweet spot: $10.0M
Range: $50K - $1.0B
Investors in New Zealand, Investors in Australia, Investors in Canada, Investors in Europe, Investors in Israel, Investors in United States
Investors in AI (Series B), Investors in Enterprise (Series B), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in SaaS (Series B), Investors in Female Investors (Other Lists), Investors in Israel (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Enterprise (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in Canada (Other Lists), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Enterprise Applications (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in SaaS (Series A), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in Consumer Health (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Pre-seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Seed), Investors in AutoTech (Series A), Investors in Health IT (Series B), Investors in AutoTech (Series B), Investors in Digital Health (Series B), Investors in AutoTech (Pre-seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series A), Investors in AutoTech (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health IT (Pre-seed), Investors in AutoTech (Series A), Investors in AutoTech (Series B), Investors in Digital Health (Series B), Investors in AutoTech (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in AutoTech (Seed), Investors in AutoTech (Seed), Investors in AutoTech (Seed), Investors in AutoTech (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Digital Health (Seed), Investors in AutoTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed)
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Hardware (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Ludovic Andre, Managing Director at Crédit Mutuel Equity
Ludovic Andre
Crédit Mutuel Equity·Managing Director
Sweet spot: $5
Range: $3 - $15
Investors in United States, Investors in Canada
Investors in Analytics (Series B), Investors in Web3/Blockchain (Series B), Investors in Analytics (Series A), Investors in AI (Series B), Investors in Cloud Infrastructure (Series B), Investors in E-commerce (Series B), Investors in Cloud Infrastructure (Series A), Investors in E-commerce (Series A), Investors in Web3/Blockchain (Series A), Investors in Health IT (Series A), Investors in SaaS (Series B), Investors in AI (Series A), Investors in Analytics (Series A), Investors in Web3/Blockchain (Series A), Investors in AI (Series A), Investors in Cloud Infrastructure (Series A), Investors in E-commerce (Series A), Investors in Health IT (Series A), Investors in SaaS (Series A), Investors in AI (Series B), Investors in Analytics (Series B), Investors in Web3/Blockchain (Series B), Investors in Cloud Infrastructure (Series B), Investors in E-commerce (Series B), Investors in Health IT (Series B), Investors in SaaS (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in SaaS (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A)
Photo of Jeffrey Kadanoff, Partner
Jeffrey Kadanoff
Partner
Sweet spot: $3.0M
Range: $500K - $10.0M
Investors in Israel, Investors in Europe, Investors in Canada, Investors in United States
Photo of Daniella Kranjac, General Partner at AVANT BIO
Daniella Kranjac
AVANT BIO·General Partner
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Switzerland, Investors in United Kingdom, Investors in Europe, Investors in Canada, Investors in United States
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Female Investors (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Investors who were founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Seed), Investors in New York City (Other Lists), Investors in Health IT (Series A), Investors in Canada (Other Lists), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed)
Photo of Yotis Tonnelier, Managing Partner at YOBE Ventures
Yotis Tonnelier
YOBE Ventures·Managing Partner
Sweet spot: $500K
Range: $25K - $2.0M
Investors in London, Investors in Canada, Investors in Europe, Investors in United States
Investors in Robotics (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Web3/Blockchain (Series B), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Seed), Investors in Investors who were founders (Other Lists), Investors in ClimateTech/CleanTech (Seed), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in Digital Health (Seed), Investors in Web3/Blockchain (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Robotics (Series B), Investors in AI (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in FinTech (Seed), Investors in Web3/Blockchain (Series A), Investors in London (Other Lists), Investors in LegalTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in Diverse Investors (Other Lists), Investors in SaaS (Series B), Investors in Investors who invested in diverse founders (Other Lists), Investors in ClimateTech/CleanTech (Series A), Investors in AI (Series B), Investors in Robotics (Series B), Investors in Real Estate/PropTech (Series B), Investors in Digital Health (Series A), Investors in Enterprise Applications (Series A), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Robotics (Series A), Investors in Robotics (Series A), Investors in Enterprise Applications (Series A), Investors in Real Estate/PropTech (Series B), Investors in AI (Series B), Investors in Web3/Blockchain (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Seed), Investors in Web3/Blockchain (Seed), Investors in AI (Series A), Investors in Robotics (Series A), Investors in AI (Series B), Investors in LegalTech (Series B), Investors in Real Estate/PropTech (Series A), Investors in Web3/Blockchain (Seed), Investors in Digital Health (Seed), Investors in Enterprise Applications (Seed), Investors in Digital Health (Series B), Investors in FinTech (Series B), Investors in AI (Series A), Investors in Real Estate/PropTech (Series A), Investors in Digital Health (Series A), Investors in SaaS (Seed), Investors in Canada (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in FinTech (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in Real Estate/PropTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in AI (Series A), Investors in Web3/Blockchain (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in FinTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Web3/Blockchain (Series B), Investors in Web3/Blockchain (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in FinTech (Series B), Investors in FinTech (Series B), Investors in SaaS (Series B), Investors in Robotics (Series B), Investors in SaaS (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Real Estate/PropTech (Series B), Investors in Enterprise Applications (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in LegalTech (Series B), Investors in LegalTech (Seed), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in LegalTech (Seed), Investors in LegalTech (Series B), Investors in LegalTech (Series A), Investors in LegalTech (Seed), Investors in LegalTech (Series A), Investors in SaaS (Seed)
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Steven Woods, Partner at iNovia Capital
Steven Woods
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada
Investors in AI (Series B), Investors in AI (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Seed), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)